INDICATIONS
ENBREL is indicated for reducing signs and symptoms, keeping joint damage from getting worse, and improving physical function in patients with moderately to severely active rheumatoid arthritis. ENBREL can be taken with methotrexate or used alone.
THINKING
ABOUT
ENBREL?
ENBREL is approved to treat
the following conditions:
Pay as little as $0*
The ENBREL Co-Pay Program may help eligible patients with commercial insurance (usually self-purchased or through an employer) lower their out-of-pocket costs for ENBREL.
- Pay as little as $0* out-of-pocket for each dose
- Can be applied to deductible, co-insurance, and co-payment*
- Support available regardless of income level
First time using a co-pay card? Find out more about how it can help you.
No insurance? Learn about other ways to access ENBREL.
*Eligibility criteria and program maximums apply. See AmgenSupportPlus.com/copay-terms for full Terms and Conditions.